Dr. Rany Condos, MD

Dr. Condos practices at NYU Langone - Tisch Hospital in New York, New York.

Dr. Condos' NPI, 1053302117, was assigned on October 28, 2005. Dr. Condos graduated from Columbia University College of Physicians and Surgeons in 1988. Dr. Condos holds New York license 182445.

Dr. Condos' primary practice is NYU Langone - Tisch Hospital, at 550 1st Ave, New York, NY 10016 in New York County. The practice phone is (212) 263-1481.

Dr. Condos' primary practice is NYU Langone - Tisch Hospital in New York, New York. Dr. Condos is also affiliated with Tisch Hospital. The medical group on file is NYU Langone Orthopedic Surgery Associates. Dmand AI also links Dr. Condos to 1 more group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Condos practices, 3 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Condos' primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Condos is licensed in New York.

CMS data shows 2,071 Medicare services from Dr. Condos across 11 procedure codes in 2024, for 355 Medicare patients. Medicare paid $130,210 for them.

CMS counts 355 Medicare patients who saw Dr. Condos in 2024. The largest group is 75 to 84, with 146 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 16% are also on Medicaid. Their average risk score is 1.83, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Condos' median patient age at 68, with 60% women.

In 2024, Dr. Condos wrote 2,220 Medicare Part D claims for 258 patients. 76% of them were for generic drugs. CMS names the drug for 1,724 of them, across 60 drugs with 11 or more claims each, at $1,335,543 in total drug cost. In 2023, CMS named 2,030 claims across 65 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Condos for performance year 2024, reported as part of a group. Dr. Condos accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Condos as offering telehealth.

Dmand AI links 15 papers to Dr. Condos, published from 2012 to 2025. 2015 was the busiest year, with 2. The most frequent topics are COVID-19, Idiopathic Pulmonary Fibrosis and Lung. Dr. Condos has published most often in Lung. Dr. Condos' most frequent co-authors are Gerald C. Smaldone, MD, PhD, Himanshu Deshwal, MD and Charlisa Deandra Gibson, MBBS.

Dmand AI links Dr. Condos to 5 clinical trials. 2 are still active or recruiting. Conditions studied include COVID-19, Cystic Fibrosis and Emphysema.

CMS Open Payments shows 285 general payments to Dr. Condos from 18 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 70% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $101,147.

Dr. Condos graduated from Columbia University College of Physicians and Surgeons in 1988.